BIOPSYCHOSOCIAL APPROACHES TO OBSESSIVE-COMPULSIVE, BODY IMAGE AND EATING DISORDERS
Dr Nicola Acevedo, Neuroscientist and Research Fellow
Swinburne University of Technology, Melbourne, Australia
& Consultant, Neurotech Insights, Melbourne, Australia &
Director, BioAutism, Melbourne, Australia & Vice-President
Australasian Brain Stimulation Society
RESEARCHER PROFILE
Filmed in Melbourne, Australia | December 2025
Dr Nicola Acevedo is a Neuroscientist and Research Fellow with extensive expertise in developing novel therapeutics for neurological and psychiatric disorders, contributing to more than ten clinical trials. She specialises in brain stimulation and psychedelic treatments for obsessive-compulsive disorder (OCD) and related conditions, with a strong commitment to advancing personalised, evidence-based neurobiological therapies for severe psychiatric illness. Her approach integrates biopsychosocial and person-centred principles to improve treatment access and mental health outcomes.
Nicola completed her PhD on deep brain stimulation for treatment-refractory OCD- described as a “tour de force”- producing eight first-author peer-reviewed publications and multiple international collaborations and papers. She now leads research in psilocybin-assisted psychotherapy for OCD, body dysmorphic disorder, and anorexia nervosa. Her work has been presented at leading international forums including Oxford and Harvard University, and the Royal Australian and New Zealand College of Psychiatrists Congress.
Alongside her research, Nicola holds leadership positions across brain stimulation, OCD, and ethics committees, serves on a peer review board, and is Director of the charity BioAutism Ltd. She also provides mentorship and supervision, with a commitment to supporting junior researchers. Her contributions have been recognised with the Early Career Researcher (ECR) Excellence Award from Biological Psychiatry Australia. As an ECR, Nicola is driven by the potential to innovate and make an impact in national mental health services.
Source: Supplied
You Might also like
-
Drug delivery of targeted therapies for pancreatic cancer, motor neurone disease
Associate Professor Kara Vine-Perrow is a cancer researcher, educator and research leader in the Faculty of Science, Medicine & Health at the University of Wollongong, where she serves as Deputy Director (Community Partnership and Impact) of the Molecular Horizons Research Institute and leads the Targeted Cancer Therapeutics Laboratory. Her research focuses on developing innovative drug delivery technologies, implantable medical devices and RNA-based therapeutics for difficult-to-treat diseases, with a particular emphasis on pancreatic cancer and motor neurone disease.
-
Influence of gut microbes and inflammation on brain function and behaviour in autism
Third-year PhD candidate Angela Jimenez is part of the Gut-Brain Axis Laboratory at RMIT University in Melbourne, Australia. Angela holds a bachelor’s degree in neuroscience (Honours) from the National Autonomous University of Mexico (UNAM), and her doctoral research is currently supported by the RMIT–Mexico International Scholarship program.
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
https://orcid.org/0000-0003-3059-3620